These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25768008)

  • 1. A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba.
    Watkins DA; Mvundura M; Nordet P; Mayosi BM
    PLoS One; 2015; 10(3):e0121363. PubMed ID: 25768008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002).
    Nordet P; Lopez R; Dueñas A; Sarmiento L
    Cardiovasc J Afr; 2008; 19(3):135-40. PubMed ID: 18568172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations.
    Watkins D; Lubinga SJ; Mayosi B; Babigumira JB
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004860. PubMed ID: 27512994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil.
    Ubels J; Sable C; Beaton AZ; Nunes MCP; Oliveira KKB; Rabelo LC; Teixeira IM; Ruiz GZL; Rabelo LMM; Tompsett AR; Ribeiro ALP; Sahlen KG; Nascimento BR;
    Glob Heart; 2020 Feb; 15(1):18. PubMed ID: 32489791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health system costs of rheumatic heart disease care in South Africa.
    Hellebo AG; Zuhlke LJ; Watkins DA; Alaba O
    BMC Public Health; 2021 Jul; 21(1):1303. PubMed ID: 34217236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Adverse Events Following Childhood Immunizations in Pinar del Río, Cuba.
    Cruz-Rodríguez E; Galindo-Santana BM; Baldoquín-Rodríguez W; Concepción-Díaz D; Luis-Martínez MC
    MEDICC Rev; 2021 Jan; 23(1):35-42. PubMed ID: 33780421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.
    Zachariah JP; Samnaliev M
    J Med Econ; 2015 Jun; 18(6):410-9. PubMed ID: 25629653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis.
    Dixit J; Prinja S; Jyani G; Bahuguna P; Gupta A; Vijayvergiya R; Kumar R
    Lancet Glob Health; 2023 Mar; 11(3):e445-e455. PubMed ID: 36796988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change.
    Katzenellenbogen JM; Bond-Smith D; Seth RJ; Dempsey K; Cannon J; Stacey I; Wade V; de Klerk N; Greenland M; Sanfilippo FM; Brown A; Carapetis JR; Wyber R; Nedkoff L; Hung J; Bessarab D; Ralph AP
    J Am Heart Assoc; 2020 Oct; 9(19):e016851. PubMed ID: 32924748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
    Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
    PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis.
    Roberts K; Cannon J; Atkinson D; Brown A; Maguire G; Remenyi B; Wheaton G; Geelhoed E; Carapetis JR
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28255077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and economic returns of group-based parenting interventions to promote early childhood development: Results from a randomized controlled trial in rural Kenya.
    Lopez Garcia I; Saya UY; Luoto JE
    PLoS Med; 2021 Sep; 18(9):e1003746. PubMed ID: 34582449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021-30: a modelling study.
    Coates MM; Sliwa K; Watkins DA; Zühlke L; Perel P; Berteletti F; Eiselé JL; Klassen SL; Kwan GF; Mocumbi AO; Prabhakaran D; Habtemariam MK; Bukhman G
    Lancet Glob Health; 2021 Jul; 9(7):e957-e966. PubMed ID: 33984296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis.
    Irlam J; Mayosi BM; Engel M; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):343-51. PubMed ID: 23652737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010.
    Lawrence JG; Carapetis JR; Griffiths K; Edwards K; Condon JR
    Circulation; 2013 Jul; 128(5):492-501. PubMed ID: 23794730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of the multi-strategy WHO emergency care toolkit in regional referral hospitals in Uganda.
    Werner K; Risko N; Kalanzi J; Wallis LA; Reynolds TA
    PLoS One; 2022; 17(12):e0279074. PubMed ID: 36516176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
    Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
    PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis 1 prevalence in children aged 9-11 years, Pinar del Río Province, Cuba.
    Orraca M; Morejón G; Cabrera N; Menéndez R; Orraca O
    MEDICC Rev; 2014; 16(3-4):22-6. PubMed ID: 25208116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial.
    Akpan E; Hossain SJ; Devine A; Braat S; Hasan MI; Tipu SMMU; Bhuiyan MSA; Hamadani JD; Biggs BA; Pasricha SR; Carvalho N
    Am J Clin Nutr; 2022 Nov; 116(5):1303-1313. PubMed ID: 36192508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.